Section 1. Short title
This Act may be cited as the Pregnancy Loss Mental Health Research Act of 2026.
(a) In general
The Secretary of Health and Human Services, acting through the Director of the National Institutes of Health and the Director of the National Institute of Mental Health (in this section referred to as the Institute), shall expand and intensify research and related activities of the Institute with respect to clinical mental health complications, including persistent complex bereavement disorder, following a pregnancy loss (including a miscarriage, stillbirth, or abortion).
(b) Coordination with other institutes
The Director of the Institute shall coordinate the activities of the Director under subsection (a) with similar activities conducted by the other national research institutes and agencies of the National Institutes of Health to the extent that such Institutes and agencies have responsibilities that are related to clinical mental health complications following a pregnancy loss (including a miscarriage, stillbirth, or abortion).
(c) Programs for pregnancy loss conditions
In carrying out subsection (a), the Director of the Institute shall conduct or support research to expand the understanding of the causes of, and to identify treatment for, mental health conditions following a pregnancy loss, including the following:
(1) Basic research concerning the etiology and causes of the conditions.
(2) The development of improved screening and diagnostic techniques.
(3) Clinical research for the development and evaluation of new treatments, including new biological agents.
(4) Information and education programs for health care professionals and the public.
(1) In general
The Director of the Institute shall conduct a national longitudinal study to determine the prevalence of mental health complications following a pregnancy loss, and the symptoms, severity, and duration of such cases, toward the goal of more fully identifying the characteristics of such cases and developing diagnostic techniques.
(2) Report
Beginning not later than 3 years after the date of enactment of this Act, and periodically thereafter for the duration of the study under paragraph (1), the Director of the Institute shall prepare and submit to the Congress a report on the findings of the study, any progress with respect to the study, and methodologies used to conduct the study.
(a) Grants
Section 317L–1(a) of the Public Health Service Act (42 U.S.C. 247b–13a(a)) is amended by striking pregnant, or have given birth within the preceding 12 months, and inserting are pregnant, have given birth within the preceding 12 months, or have experienced a pregnancy loss.
(b) Use of funds
Paragraphs (1)(C) and (2)(C) of section 317L–1(d) of the Public Health Service Act (42 U.S.C. 247b–13a(d)) are amended by inserting and women who have experienced a pregnancy loss after pregnant and postpartum women.
(c) Dissemination of best practices
Section 317L–1(f) of the Public Health Service Act (42 U.S.C. 247b–13a(f)) is amended by inserting and for women who have experienced a pregnancy loss before the period at the end.
(d) Special rules
Section 317L–1 of the Public Health Service Act (42 U.S.C. 247b–13a) is amended—
(1) by redesignating subsection (h) as subsection (i); and
(2) by inserting after subsection (g) the following:
(1) In general
In addition to the activities described in subsection (d), grant funds received by an entity under subsection (a) may be used for projects for the establishment, operation, and coordination of effective and cost-efficient systems for the delivery of mental health services to individuals struggling with clinical mental health conditions following a pregnancy loss.
(2) Certain activities
Projects referred to in paragraph (1) may include providing services for the screening, diagnosis, and management of mental health conditions, including persistent complex bereavement disorders, following a pregnancy loss, including—
(A) delivering or enhancing outpatient and home-based health and support services (including case management, screening, and mental health treatment services) for individuals with, or who are at risk of developing, mental health complications following a pregnancy loss, and delivering or enhancing support services for the families of such individuals;
(B) delivering or enhancing inpatient care management services that ensure the well-being of the mother and family; and
(C) improving the quality, availability, and organization of health care and support services (including transportation services, attendant care, homemaker services, day or respite care, and providing counseling on financial assistance and insurance) for individuals with mental health conditions following a pregnancy loss.
(3) Subgrant recipients
An entity receiving a grant under subsection (a) may carry out projects described in paragraph (1) by making subgrants to an entity (other than a prohibited entity) that—
(A) is a public or nonprofit private entity, which may include—
(i) a State, Tribal, or local governmental entity;
(ii) a public or nonprofit private hospital, community-based organization, community health center, migrant health center, or homeless health center; or
(iii) other appropriate public or nonprofit private entity; and
(B) has experience in providing services for projects described in paragraph (1).
(A) In general
For purposes of paragraph (3), the term prohibited entity means an entity, including its affiliates, subsidiaries, successors, and clinics, that performs, or provides any funds to any other entity that performs, abortions, other than—
(i) in the case of a pregnancy that is the result of an act of rape or incest; or
(ii) in the case where a woman suffers from a physical disorder, physical injury, or physical illness that would, as certified by a physician, place the woman in danger of death unless an abortion is performed, including a life endangering physical condition caused by, or arising from, the pregnancy itself.
(B) End of prohibition
The definition in subparagraph (A) shall cease to apply to an entity if such entity certifies that the entity, including its affiliates, subsidiaries, successors, and clinics, will not perform, and will not provide any funds to any other entity that performs, an abortion described in subparagraph (A).
(C) Repayment by prohibited entity
The Secretary shall seek repayment of any Federal assistance received by any entity that makes a certification described in subparagraph (B) and subsequently violates the terms of such certification.
(5) Terms and conditions
An entity receiving a grant under subsection (a) to carry out projects described in paragraph (1) shall be subject to the following terms and conditions:
(A) Not more than 5 percent of the grant will be used for administration, accounting, reporting, and program oversight functions.
(B) The grant will be used to supplement and not supplant funds from other sources related to the treatment of clinical mental health conditions following a pregnancy loss.
(C) The applicant will abide by any limitations deemed appropriate by the Secretary on any charges to individuals receiving services pursuant to the grant. As determined appropriate by the Secretary, such limitations on charges may vary based on the financial circumstances of the individual receiving services.
(D) The grant will not be expended to make payment for services to the extent that payment has been made, or can reasonably be expected to be made, with respect to such services—
(i) under any State compensation program, under an insurance policy, or under any Federal or State health benefits program; or
(ii) by an entity that provides health services on a prepaid basis.